Crown Point, IN – December 16, 2025 — OYE Therapeutics, a clinical-stage pharmaceutical company developing a caffeine platform for anesthesia recovery and opioid-induced respiratory depression (OIRD), announced that on November 28, 2025 it had raised $5.475 million in a Series...